跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 45,930 条关于
“Dasher Neuroscience Holdings Inc.”
全部
45,930
临床试验
15,149
药物
1,707
机构
6,331
资讯
22,743
上个月
Dasher Neuroscience Completes Patient Enrollment in Phase 2 Trial of YA-101 for Multiple System Atrophy
去年
ALX Oncology's Evorpacept Shows Promise in Multiple Cancer Trials
去年
CERO Therapeutics' CER-1236 Receives FDA Clearance for Clinical Trials
2年前
enGene Appoints Dr. Raj Pruthi as SVP to Advance EG-70 in Urologic Oncology
2年前
Ignite Proteomics' RPPA Assay Drives Complete Response in HER2-Negative Breast Cancer
去年
Matinas BioPharma's MAT2203 Shows Promise in Combating Severe Fungal Infections
去年
Senseonics Reports Q3 2024 Results and FDA Approval of Eversense 365
去年
Shuttle Pharmaceuticals Announces $4.5 Million Public Offering to Advance Ropidoxuridine Clinical Trials
去年
ME Therapeutics Advances Anti-G-CSF Antibody for Cancer Immunotherapy
去年
Aspire Biopharma Holdings, Inc., Provides Development Update on BUZZ BOMB(TM ... - USA Today
第 1 页,共 2275 页
上一页
下一页